Literature DB >> 17005794

Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit.

Maria Horianopoulou, Nicholas J Legakis1, Maria Kanellopoulou, Sotiris Lambropoulos, Athanassios Tsakris1, Matthew E Falagas2,3.   

Abstract

The aim of this study was to examine the frequency and predictors of colonization of the respiratory tract by metallo-beta-lactamase (MBL)-producing Gram-negative bacteria in patients admitted to a newly established intensive care unit (ICU) of a tertiary care hospital. Specimens of tracheobronchial aspirates for microbiological studies were obtained every day for the first 3 days of the ICU stay and subsequently every third day for the rest of the ICU stay. PCR analysis and nucleotide sequencing were performed to identify bacteria that had MBL genes. Thirty-five patients (20 male, 15 female) were hospitalized during the initial 3 month period of functioning of the ICU. Colonization of the lower respiratory tract by Gram-negative bacteria was found in 29 of 35 patients (83 %) during the first 6-20 days (median 13 days) following admission to the ICU (13 patients with Acinetobacter baumannii, ten with Pseudomonas aeruginosa, three with Enterobacter aerogenes, two with Klebsiella pneumoniae and one with Stenotrophomonas maltophilia). Six of 29 patients (21 %) colonized with Gram-negative bacteria had bla(VIM-2)-positive P. aeruginosa isolates; one of these patients developed clinical infection due to this micro-organism. Previous use of carbapenems (P=0.01) or other beta-lactams (P=0.03), as well as a stay in the ICU of >20 days (P<0.001), were associated with colonization with bla(VIM-2)-producing P. aeruginosa. In conclusion, colonization by Gram-negative bacteria of the respiratory tract of patients in this newly established ICU was common (83 %). Use of beta-lactams, including carbapenems, was associated with subsequent colonization of the respiratory tract with MBL-positive P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005794     DOI: 10.1099/jmm.0.46713-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia.

Authors:  Yingjie Zhou; Jing Zhang; Yuancheng Chen; Jufang Wu; Beining Guo; Xiaojie Wu; Yingyuan Zhang; Minggui Wang; Ru Ya; Hao Huang
Journal:  Antibiotics (Basel)       Date:  2022-05-23

2.  Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections.

Authors:  Athanassios Tsakris; Aggeliki Poulou; Ioulia Kristo; Theodore Pittaras; Nicholas Spanakis; Spyros Pournaras; Fani Markou
Journal:  J Clin Microbiol       Date:  2009-09-23       Impact factor: 5.948

Review 3.  Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.

Authors:  Theodoros Karampatakis; Charalampos Antachopoulos; Athanassios Tsakris; Emmanuel Roilides
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-11       Impact factor: 3.267

4.  The characteristics of metallo-β-lactamase-producing gram-negative bacilli isolated from sputum and urine: a single center experience in Korea.

Authors:  Bum Sik Chin; Sang Hoon Han; Suk Hoon Choi; Han Sung Lee; Su Jin Jeong; Hee Kyung Choi; Jun Yong Choi; Young Goo Song; Chang Ki Kim; Dongeun Yong; Kyungwon Lee; June Myung Kim
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

Review 5.  Epidemiology of VIM-1-imipenem resistant Pseudomonas aeruginosa in Iran: A systematic review and meta-analysis.

Authors:  Mansour Sedighi; Amin Salehi-Abargouei; Golfam Oryan; Jamshid Faghri
Journal:  J Res Med Sci       Date:  2014-09       Impact factor: 1.852

6.  Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment.

Authors:  Eva Raphael; Lee W Riley
Journal:  Front Med (Lausanne)       Date:  2017-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.